Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a trial of TCN-032 in human H3N2 influenza A challenge
2012-000854-73Phase 2Completed
- Sponsor
- Theraclone Sciences
- Start
- Apr 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A infection comparing TCN-032 with Placebo (2 arms). Primary endpoint: Primary clinical endpoint. Started Apr 2012; status: completed.
02
Drugs
TCN-032
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2012-000854-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000854-73.